Biocon gets supplemental US FDA nod for Yesintek prefilled autoinjector
Biocon said that its US subsidiary has received supplemental U.S. Food and Drug Administration (FDA) approval for Yesintek (ustekinumab-kfce) single-dose prefilled autoinjector in various strengths.
